Association between sclerostin and bone density in chronic spinal cord injury
about
Osteoporosis and obesity: Role of Wnt pathway in human and murine modelsAnalyzing time-series microarray data reveals key genes in spinal cord injury.A review of osteocyte function and the emerging importance of sclerostinSpinal Cord Injury and Osteoporosis: Causes, Mechanisms, and Rehabilitation StrategiesThe Wnt Inhibitor Sclerostin Is Up-regulated by Mechanical Unloading in Osteocytes in Vitro.Circulating sclerostin is elevated in short-term and reduced in long-term SCI.Serum sclerostin increases in healthy adult men during bed rest.Spinal cord injury-induced osteoporosis: pathogenesis and emerging therapies.Serum Sclerostin Levels in Patients with Human Immunodeficiency Virus Infection and Their Association with Bone Turnover Markers and Bone Mineral DensitometrySclerostin: a candidate biomarker of SCI-induced osteoporosisB-cell maturation antigen, a proliferation-inducing ligand, and B-cell activating factor are candidate mediators of spinal cord injury-induced autoimmunityClinical utility of serum sclerostin measurements.Adiponectin is a candidate biomarker of lower extremity bone density in men with chronic spinal cord injury.Participation in organized sports is positively associated with employment in adults with spinal cord injury.Spaceflight-induced bone loss: is there an osteoporosis risk?The role of Wnt signaling and sclerostin in the pathogenesis of glucocorticoid-induced osteoporosis.Osteoporosis in adults with cerebral palsy: feasibility of DXA screening and risk factors for low bone density.Bone loss at the distal femur and proximal tibia in persons with spinal cord injury: imaging approaches, risk of fracture, and potential treatment options.Hormonal and systemic regulation of sclerostin.Nitric oxide is involved in the down-regulation of SOST expression induced by mechanical loading.Sclerostin inhibition prevents spinal cord injury-induced cancellous bone loss.Low bone mineral density and fragility fractures in permanent vegetative state patients.Evaluating the efficacy of functional electrical stimulation therapy assisted walking after chronic motor incomplete spinal cord injury: effects on bone biomarkers and bone strength.Wheelchair use and lipophilic statin medications may influence bone loss in chronic spinal cord injury: findings from the FRASCI-bone loss study.Role of Inactivity in Chronic Diseases: Evolutionary Insight and Pathophysiological Mechanisms.Serum Sclerostin Levels in Adults With Osteogenesis Imperfecta: Comparison With Normal Individuals and Response to Teriparatide Therapy.Serum Sclerostin Increases After Acute Physical Activity.Mice with sclerostin gene deletion are resistant to the severe sublesional bone loss induced by spinal cord injury.Evaluation of serum myostatin and sclerostin levels in chronic spinal cord injured patients.
P2860
Q27026535-4EC80CA8-C433-48A6-AF56-017448C08EEFQ30838780-DDE486BC-AE10-4C9A-953C-FF06D8F96946Q34264395-200B4A65-774B-4A68-B5D8-DC6B3D9F6E33Q34547308-268F7F46-E000-4FB1-AAF5-CF5AB37D9A00Q35860523-7E67BEED-CFD9-458C-BC35-E67DBAD99EF5Q36143807-315608D5-860E-4F2E-AFAB-3FED6ADDC051Q36201481-99472E84-1837-4741-8A5B-FE19DD6A5F70Q36428144-2AAE9A84-3496-44BC-AF30-F3C7378913E0Q36685956-9480FB1F-96A7-4AB6-BF0A-B55111D367C9Q36725899-B0B7AD8F-1385-4702-9F68-738EBFC1592BQ36768876-576B78C5-4622-4A8E-AD45-A22BF15F00CCQ37605570-5C185658-8D7F-4EC2-AE07-39E8E11F7B65Q37691723-3816FFD9-6238-471A-892C-6632E41DD0FCQ37696058-137BEBA6-A2E3-4844-A43D-417D600ACBFFQ38096943-C99A4D8D-A4C2-48EF-9BBD-B2B2BFDBD249Q38184470-FB8340AC-24CF-482E-9E86-58934CEA50C0Q38635771-F3D8F9F5-C222-4918-833F-9A489D151F62Q39030288-7D25FB4E-38B3-4AE8-B2F4-69B9AD687762Q39037907-B241FA54-4276-4C86-BC87-CB6BFE18E45AQ39045041-7BE8E021-ADF0-44E7-9767-71ECD4AA6F10Q39105382-07CBB76A-23BE-40C7-A310-E4B82BC99E4CQ45987969-AC21232D-027C-485F-A79A-152476325CE5Q47655582-4ED730EF-C498-4944-B1F6-15FF9552DC5CQ47837437-E1C5E384-3878-481B-9621-CCA00F4B659AQ48228971-364536BB-16EA-4E26-81C6-DDC70C616E77Q50088169-6B403C4F-E64E-4BC0-A7A7-D88551304BD5Q50751681-3C1DD3A3-65D4-4CB1-8E75-4770BB83BBE9Q50874426-281C5B76-B383-4125-9E6E-F0ECB89F95C4Q50927799-054870D8-261E-42BE-A34A-F3FE4B8215A1
P2860
Association between sclerostin and bone density in chronic spinal cord injury
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Association between sclerostin and bone density in chronic spinal cord injury
@ast
Association between sclerostin and bone density in chronic spinal cord injury
@en
type
label
Association between sclerostin and bone density in chronic spinal cord injury
@ast
Association between sclerostin and bone density in chronic spinal cord injury
@en
prefLabel
Association between sclerostin and bone density in chronic spinal cord injury
@ast
Association between sclerostin and bone density in chronic spinal cord injury
@en
P2093
P2860
P356
P1476
Association between sclerostin and bone density in chronic spinal cord injury
@en
P2093
Antonio Lazzari
Carlos Tun
Eric Garshick
Leslie R Morse
Ricardo A Battaglino
Supreetha Sudhakar
Valery Danilack
P2860
P304
P356
10.1002/JBMR.546
P577
2012-02-01T00:00:00Z